New York, NY, United States of America

Vinod P Balachandran

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Vinod P Balachandran: Innovator in Cancer Treatment

Introduction

Vinod P Balachandran is a prominent inventor based in New York, NY (US). He has made significant contributions to the field of cancer treatment through his innovative research and patented technologies. His work focuses on the development of systems and methods that enhance the effectiveness of immunotherapy for cancer patients.

Latest Patents

Vinod P Balachandran holds a patent for "Neoantigens and uses thereof for treating cancer." This patent outlines systems and methods for determining the likely responsiveness of a human cancer subject to a checkpoint blockade immunotherapy regimen. The process involves obtaining sequencing reads from cancer samples, determining human leukocyte antigen types, and computing clone fitness scores based on neoantigens. This innovative approach aims to quantify the responsiveness of cancer subjects to immunotherapy regimens.

Career Highlights

Throughout his career, Balachandran has worked with esteemed institutions, including the Icahn School of Medicine at Mount Sinai. His research has contributed to advancing the understanding of cancer treatment and improving patient outcomes.

Collaborations

Vinod P Balachandran has collaborated with notable colleagues, including Marta Luksza and Arnold J Levine. These partnerships have fostered a collaborative environment that enhances the research and development of cancer therapies.

Conclusion

Vinod P Balachandran's innovative work in cancer treatment exemplifies the impact of research and patents in advancing medical science. His contributions continue to pave the way for improved therapies and better patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…